Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Depreciation and Depletion: 2014-2025

Historic Depreciation and Depletion for Myriad Genetics (MYGN) over the last 11 years, with Sep 2025 value amounting to $4.8 million.

  • Myriad Genetics' Depreciation and Depletion changed negligibly% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 6.45%. This contributed to the annual value of $19.5 million for FY2024, which is 2.09% up from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Depreciation and Depletion is $4.8 million, which was down 2.04% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Depreciation and Depletion registered a high of $8.7 million during Q1 2023, and its lowest value of $2.6 million during Q3 2021.
  • For the 3-year period, Myriad Genetics' Depreciation and Depletion averaged around $4.8 million, with its median value being $4.8 million (2025).
  • Per our database at Business Quant, Myriad Genetics' Depreciation and Depletion surged by 210.71% in 2023 and then tumbled by 43.68% in 2024.
  • Over the past 5 years, Myriad Genetics' Depreciation and Depletion (Quarterly) stood at $3.2 million in 2021, then declined by 3.12% to $3.1 million in 2022, then skyrocketed by 38.71% to $4.3 million in 2023, then rose by 16.28% to $5.0 million in 2024, then remained steady at $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $4.9 million for Q2 2025, and $5.1 million during Q1 2025.